Mustang Bio Reports First Quarter 2021 Financial Results and Recent Corporate Highlights

Non-cash, stock-based expenses included in research and development were $0.7 million for the first quarter of 2021, compared to $0.4 million for the first quarter of 2020.\nGeneral and administrative expenses were $3.5 million for the first quarter of 2021, compared to $2.0 million for the first quarter of 2020.